Renal cancer: new models and approach for personalizing therapy

BACKGROUND: Clear cell RCC (ccRCC) accounts for approximately 75% of the renal cancer cases. Surgery treatment seems to be the best efficacious approach for the majority of patients. However, a consistent fraction (30%) of cases progress after surgery with curative intent. It is currently largely de...

Descripción completa

Detalles Bibliográficos
Autores principales: di Martino, Simona, De Luca, Gabriele, Grassi, Ludovica, Federici, Giulia, Alfonsi, Romina, Signore, Michele, Addario, Antonio, De Salvo, Laura, Francescangeli, Federica, Sanchez, Massimo, Tirelli, Valentina, Muto, Giovanni, Sperduti, Isabella, Sentinelli, Steno, Costantini, Manuela, Pasquini, Luca, Milella, Michele, Haoui, Mustapha, Simone, Giuseppe, Gallucci, Michele, De Maria, Ruggero, Bonci, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126022/
https://www.ncbi.nlm.nih.gov/pubmed/30185225
http://dx.doi.org/10.1186/s13046-018-0874-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126022/
https://www.ncbi.nlm.nih.gov/pubmed/30185225
http://dx.doi.org/10.1186/s13046-018-0874-4

Ejemplares similares